SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-11-333944
Filing Date
2011-12-08
Accepted
2011-12-07 19:46:47
Documents
7
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d263633d10ka.htm 10-K/A 3141088
2 CONSENT OF BDO USA, LLP d263633dex231.htm EX-23.1 3057
3 EXHIIBIT 31.1 d263633dex311.htm EX-31.1 9146
4 EXHIBIT 31.2 d263633dex312.htm EX-31.2 9127
5 EXHIBIT 32.1 d263633dex321.htm EX-32.1 4938
6 EXHIBIT 32.2 d263633dex322.htm EX-32.2 4895
7 GRAPHIC g263633g24x93.jpg GRAPHIC 65054
  Complete submission text file 0001193125-11-333944.txt   3263021
Mailing Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044
Business Address ONE CORPORATE WOODS DRIVE BRIDGETON MO 63044 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-09601 | Film No.: 111249678
SIC: 2834 Pharmaceutical Preparations